Can liver transplantation provide the statistical cure?

Area of Science:

• Hepatology and Transplant Surgery
• Biostatistics and Survival Analysis

Background:

• Liver transplantation (LT) is the sole curative option for end-stage liver disease.
• Defining statistical cure after LT is crucial for assessing long-term outcomes.
• Previous cure models have not been applied to liver transplant recipients.

Purpose of the Study:

• To establish probabilities of achieving a statistical cure after liver transplantation.
• To apply cure models to a large cohort of liver transplant recipients.
• To identify factors influencing the likelihood and time to cure post-LT.

Main Methods:

• Retrospective analysis of 1371 adult patients undergoing primary LT.
• Application of a parametric Weibull model to compare post-LT mortality with general population rates.
• Matching of general population mortality data by age and sex.

Main Results:

• The overall cure fraction was 63.4%, with an estimated 10-year time to cure.
• Younger recipients without Hepatitis C Virus (HCV) and favorable Donor Model for End-Stage Liver Disease (D-MELD) scores had the highest cure fraction (90.1%).
• Elderly HCV recipients with high D-MELD scores had the lowest cure fraction (34.6%).

Conclusions:

• This study introduces a novel clinical measure for LT, demonstrating that survival can approximate the general population, signifying a statistical cure.
• Time to cure varied significantly based on recipient age, HCV status, and D-MELD score.
• The findings provide valuable insights into long-term outcomes and patient stratification after liver transplantation.